[The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy].
To study the mechanism of bystander effect in herpes simplex virus thymidine kinase (HSV-TK)/Ganciclovir (GCV)-mediated gene therapy. Recombinant retroviral vectors expressing HSV-TK and beta-Galactosidase (Lac Z) genes were constructed and transferred into pancreatic carcinoma cell line respectively. Cell counting was used to detect the growth inhibition rate of HSV-TK-transduced cells in presence of GCV. Taking Lac Z-transduced cells as bystander cells, the bystander effect was detected by MTT method, and its mechanism was studied by the experiments of supernatant shifting, Verapamil inhibition and ultrastructural observation. The growth inhibition rate of the HSV-TK-transduced cells in the presence of GCV was 92.1%, which was obviously 4.9% and 3.2% higher than of the non-and control vector-transduced cells. Mixed cells containing only 10% of HSV-TK-transduced cells showed 39.0% reduction of the proliferation, which meant there was an obvious bystander effect in the system. However this effect disappeared when transferring GCV-containing supernatant of HSV-TK-transduced cells to the parent cells and could be reduced significantly when verapamil was added in the medium, indicating that this bystander effect requires cell-cell contact. Gap junctions were observed existing between PC-2 cells by electron microscopy. The bystander effect in HSV-TK/GCV-mediated gene therapy occurs by transfer of GCV metabolite from cell to cell through gap junction.